NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML

被引:52
|
作者
Jayavelu, Ashok Kumar [1 ]
Moloney, Jennifer N. [2 ]
Boehmer, Frank-D. [1 ]
Cotter, Thomas G. [2 ]
机构
[1] Jena Univ Hosp, CMB, Inst Mol Cell Biol, Hans Knoll Str 2, D-07745 Jena, Germany
[2] Univ Coll Cork, Biosci Res Inst, Sch Biochem & Cell Biol, Tumour Biol Lab, Cork, Ireland
关键词
PROTEIN-TYROSINE PHOSPHATASES; ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATIONS; BCR-ABL; GENOMIC INSTABILITY; NADPH OXIDASES; DNA-DAMAGE; FLT3; ACTIVATION; MECHANISMS;
D O I
10.1016/j.exphem.2016.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In different types of myeloid leukemia, increased formation of reactive oxygen species (ROS) has been noted and associated with aspects of cell transformation, including the promotion of leukemic cell proliferation and migration, as well as DNA damage and accumulation of mutations. Work reviewed in this article has revealed the involvement of NADPH oxidase (NOX)-derived ROS downstream of oncogenic protein tyrosine kinases in both processes, and the related pathways have been partially identified. FMS-like tyrosine kinase 3 with internal tandem duplications (FLT3-ITD), an important oncoprotein in a subset of acute myeloid leuke-mias, causes activation of AKT and, subsequently, stabilization of p22(phox), a regulatory subunit for NOX1-4. This process is linked to ROS formation and DNA damage. Moreover, FLT3-ITD signaling through STAT5 enhances expression of NOX4, ROS formation, and inactivation of the protein tyrosine phosphatase DEP-1/PTPRJ, a negative regulator of FLT3 signaling, by reversible oxidation of its catalytic cysteine residue. Genetic inactivation of NOX4 restores DEP-1 activity and attenuates cell transformation by FLT3-ITD in vitro and in vivo. Future work is required to further explore these mechanisms and their causal involvement in leukemic cell transformation, which may result in the identification of novel candidate targets for therapy. Copyright (C) 2016 ISEH-International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:1113 / 1122
页数:10
相关论文
共 50 条
  • [21] CCL5 mediates Target-Kinase independent resistance to FLT3 Inhibitors in FLT3-ITD-positive AML
    Waldeck, S.
    Rassner, M.
    Keye, P.
    Duyster, J.
    von Bubnoff, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 19 - +
  • [22] Characteristics and Outcome of FLT3-ITD-Positive Acute Myeloid Leukemia
    Li, Hong
    Wang, Lingling
    Mu, Jiao
    CLINICAL LABORATORY, 2024, 70 (11) : 2125 - 2131
  • [23] CCL5 Mediates Target-Kinase Independent Resistance to FLT3 Inhibitors in FLT3-ITD-Positive AML
    Waldeck, Silvia
    Rassner, Michael
    Keye, Philip
    von Bubnoff, Nikolas
    Duyster, Justus
    BLOOD, 2017, 130
  • [24] CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
    Waldeck, Silvia
    Rassner, Michael
    Keye, Philip
    Follo, Marie
    Herchenbach, Dieter
    Endres, Cornelia
    Charlet, Anne
    Andrieux, Geoffroy
    Salzer, Ulrich
    Boerries, Melanie
    Duyster, Justus
    von Bubnoff, Nikolas
    MOLECULAR ONCOLOGY, 2020, 14 (04) : 779 - 794
  • [25] Case Report of FLT3-ITD-Positive AML Patient 11 Years After Living Donor Liver Transplantation
    Taniai, N.
    Yoshida, H.
    Kawano, Y.
    Uchida, E.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (03) : 1003 - 1005
  • [26] Myelomonocytic differentiation of leukemic blasts accompanied by differentiation syndrome in a case of FLT3-ITD-positive AML treated with gilteritinib
    Kondo, Takeshi
    Onozawa, Masahiro
    Fujisawa, Shinichi
    Harada, Shinpei
    Ogasawara, Reiki
    Izumiyama, Koh
    Saito, Makoto
    Morioka, Masanobu
    Mori, Akio
    Teshima, Takanori
    HEMATOLOGY, 2021, 26 (01) : 256 - 260
  • [27] Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT
    Shi, Jimin
    Cao, Liqin
    Luo, Yi
    Zhao, Yanmin
    Tan, Yamin
    Yu, Jian
    Lai, Xiaoyu
    Zhu, Yuanyuan
    Hu, Yongxian
    He, Jingsong
    Sun, Jie
    Zheng, Weiyan
    Wei, Guoqing
    Huang, He
    BLOOD, 2019, 134
  • [28] Genomic Profiling Identifies Novel Mutations and Fusion Genes in Newly Diagnosed and Relapsed Pediatric FLT3-ITD-Positive AML
    Buelow, Daelynn R.
    Pounds, Stanley
    Wang, Yong-Dong
    Shi, Lei
    Li, Yongjin
    Finkelstein, David
    Shurtleff, Sheila A.
    Neale, Geoffrey A.
    Inaba, Hiroto
    Ribeiro, Raul C.
    Garrison, Dominique
    Orwick, Shelley
    Blachly, James S.
    Byrd, John C.
    Kroll, Karl
    Gruber, Tanja A.
    Rubnitz, Jeffrey E.
    Baker, Sharyn D.
    BLOOD, 2016, 128 (22)
  • [29] Relapse Mechanism of FLT3-ITD Positive AML and Cell Differentiation Blockage
    Hayun, Michal
    Zaatra, Maria
    Itzkovitch, Chen
    Sahar, Dvora
    Dann, Eldad J.
    Louria-Hayon, Igal
    Ofran, Yishai
    BLOOD, 2015, 126 (23)
  • [30] IMPACT OF THE E3 UBIQUITIN LIGASE TRAF2 ON TNF-A-INDUCED APOPTOSIS IN A CELL MODEL OF FLT3-ITD-POSITIVE AML
    Schnetzke, U.
    Fischer, M.
    Spies-Weisshart, B.
    Mueller, J.
    Hochhaus, A.
    Scholl, S.
    HAEMATOLOGICA, 2013, 98 : 275 - 276